June 13, 2025 When The Game Changed: What Chronic Kidney Disease Taught Me About Men’s Health Seeing as how this is a C-Path piece, I suppose it may be prudent to introduce myself to those in our community...
June 9, 2025 Delivering regulatory impact from consortium-based projects Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of...
June 4, 2025 C-Path’s Translational Therapeutics Accelerator, Sontag Foundation Award Grant for Drug Development Project Targeting Pediatric Brain Tumors C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program...
June 2, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series Session #4: Case Studies #3 – Data Sharing Collaboratives Critical Path Institute's Critical Path for Lysosomal Diseases (CPLD) Consortium presents, Lysosomal Storage Disease...
May 13, 2025 Considerations and Approaches to Establishing Estimates of Meaningful Change for Digital Endpoints as Drug Development Tools This paper seeks to identify some of the complexities associated with determining meaningful change for endpoints derived from...
May 29, 2025 Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders C-Path, a global nonprofit accelerating drug development through data science and regulatory...
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium...
May 20, 2025 The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations...
May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian...